Molecular structure of Sodium selenate, CAS Number: 13410-01-0
Sodium selenate (CAS 13410-01-0)
CAS Number:
13410-01-0
Molecular Weight:
188.94
Molecular Formula:
Na2SeO4
Supplemental Information:
This is classified as a Dangerous Good for transport and may be subject to additional shipping charges.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
Sodium selenate, a soluble form of selenium, is extensively used in research applications that require a reliable source of this trace element. In the field of plant sciences, sodium selenate is applied to study selenium uptake and assimilation in plants, offering insights into how this essential micronutrient impacts plant growth and development. Environmental scientists are interested in its behavior in soil and water systems, investigating its mobility and bioavailability, which are for understanding the cycling of selenium in the environment. In nutritional studies, this compound aids research into selenium deficiency and its impact on health in various systems. Additionally, sodium selenate serves as a reagent in the synthesis of selenium-containing compounds, which are of interest in various chemical reactions and material properties due to selenium′s unique redox characteristics.
Sodium selenate (CAS 13410-01-0) References
- Sodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer's disease models. | van Eersel, J., et al. 2010. Proc Natl Acad Sci U S A. 107: 13888-93. PMID: 20643941
- Targeting hyperphosphorylated tau with sodium selenate suppresses seizures in rodent models. | Jones, NC., et al. 2012. Neurobiol Dis. 45: 897-901. PMID: 22182692
- Sodium selenate reduces hyperphosphorylated tau and improves outcomes after traumatic brain injury. | Shultz, SR., et al. 2015. Brain. 138: 1297-313. PMID: 25771151
- Sodium selenate, a protein phosphatase 2A activator, mitigates hyperphosphorylated tau and improves repeated mild traumatic brain injury outcomes. | Tan, XL., et al. 2016. Neuropharmacology. 108: 382-93. PMID: 27163189
- Sodium selenate retards epileptogenesis in acquired epilepsy models reversing changes in protein phosphatase 2A and hyperphosphorylated tau. | Liu, SJ., et al. 2016. Brain. 139: 1919-38. PMID: 27289302
- Sodium selenate treatment mitigates reduction of bone volume following traumatic brain injury in rats. | Brady, RD., et al. 2016. J Musculoskelet Neuronal Interact. 16: 369-376. PMID: 27973389
- Sodium selenate regulates the brain ionome in a transgenic mouse model of Alzheimer's disease. | Zheng, L., et al. 2016. Sci Rep. 6: 39290. PMID: 28008954
- Sodium selenate treatment improves symptoms and seizure susceptibility in a malin-deficient mouse model of Lafora disease. | Sánchez-Elexpuru, G., et al. 2017. Epilepsia. 58: 467-475. PMID: 28098937
- Sodium selenate activated Wnt/β-catenin signaling and repressed amyloid-β formation in a triple transgenic mouse model of Alzheimer's disease. | Jin, N., et al. 2017. Exp Neurol. 297: 36-49. PMID: 28711506
- Protection of rice against Nilaparvata lugens by direct toxicity of sodium selenate. | Scheys, F., et al. 2020. Arch Insect Biochem Physiol. 103: e21644. PMID: 31702082
- Sodium Selenate Ameliorates Cardiac Injury Developed from High-Fat Diet in Mice through Regulation of Autophagy Activity. | Zhang, S., et al. 2019. Sci Rep. 9: 18752. PMID: 31822702
- Application of sodium selenate to cowpea (Vigna unguiculata L.) increases shoot and grain Se partitioning with strong genotypic interactions. | Silva, VM., et al. 2021. J Trace Elem Med Biol. 67: 126781. PMID: 34015659
- Sodium selenate as a disease-modifying treatment for progressive supranuclear palsy: protocol for a phase 2, randomised, double-blind, placebo-controlled trial. | Vivash, L., et al. 2021. BMJ Open. 11: e055019. PMID: 34916328
- Effect of Foliar Sodium Selenate and Nano Selenium Supply on Biochemical Characteristics, Essential Oil Accumulation and Mineral Composition of Artemisia annua L. | Logvinenko, L., et al. 2022. Molecules. 27: PMID: 36500339
- Disease-modifying effects of sodium selenate in a model of drug-resistant, temporal lobe epilepsy. | Casillas-Espinosa, PM., et al. 2023. Elife. 12: PMID: 36892461
Inhibitor of:
Tau-1.Activator of:
CDNF, dendrin, FND3C2, POFUT2, PP2A-β, PP2A-Aβ, PP2A-B55-α, SELENBP2, Selenoprotein I, Selenoprotein M, Selenoprotein O, Selenoprotein V, SEP15, ZFP322a, ZFP39, ZFP59, ZFP712, ZFP81, ZFP839, ZNF391, and ZP3R.Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Sodium selenate, 25 g | sc-251052A | 25 g | $51.00 | |||
Sodium selenate, 100 g | sc-251052 | 100 g | $183.00 | |||
Sodium selenate, 500 g | sc-251052B | 500 g | $325.00 | |||
Sodium selenate, 1 kg | sc-251052C | 1 kg | $587.00 |